Fibre and Mental Wellbeing Feasibility Trial
Launched by UNIVERSITY OF READING · Mar 25, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Fibre and Mental Wellbeing Feasibility Trial is a study designed to see if adding an extra 10 grams of fibre to people's daily diet for two weeks can help improve their mental health and overall wellbeing. The researchers are particularly interested in how this might affect feelings of stress, anxiety, and sleep quality. This study is looking for participants aged 18 to 40 who don’t already eat a lot of fibre (more than 20 grams a day), have normal vision and hearing, and have a healthy weight.
If you join the trial, you would be asked to increase your fibre intake for two weeks while keeping your regular diet. It’s important to note that some people won't be able to participate, such as those who smoke, have certain medical conditions, or are taking specific medications. The trial is not yet recruiting, so there’s still time to learn more about it before it begins. Your involvement could help researchers understand the connection between diet and mental health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aging between 18-40 years old
- • Having normal vision and hearing
- • Having a body mass index between 18.5 and 30
- • Not following a high fibre diet \>20g fibre/day as assessed by using the FiberScreen
- Exclusion Criteria:
- • Smoking
- • Having food allergies
- • Following restrictive and/or unbalanced diets
- • Changing dietary intake majorly in past month
- • Being diagnosed with any psychiatric or neurologic conditions
- • Being diagnosed with any cardiometabolic diseases, or hypertension or thrombosis related disorders or suffer from thyroid disease
- • Currently taking anticoagulants, antiplatelet medication, antidepressants, proton-pump inhibitors
- • Currently consuming prebiotic or probiotic supplements or laxatives
- • Continuous antibiotic use for \> 3 days within 1 month prior to enrolment
- • Continuous use of weight-loss drug for \> 1 month before screening
- • Having a significant gastrointestinal (GI) condition
About University Of Reading
The University of Reading is a prestigious research institution in the United Kingdom, renowned for its commitment to advancing knowledge across various disciplines, including health sciences. As a clinical trial sponsor, the university leverages its cutting-edge research facilities and interdisciplinary expertise to conduct innovative studies aimed at improving healthcare outcomes. With a strong emphasis on ethical research practices and collaboration with industry partners, the University of Reading strives to contribute valuable insights to the field of medicine, fostering the development of new treatments and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reading, Berkshire, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported